Related Experiment Video
Updated: Sep 30, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Central aortic pressure augmentation in stable renal transplant recipients
Charles J Ferro1, Tessa Savage, Sarah J Pinder
1The Richard Bright Kidney Unit, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, England, UK. charlesferro@hotmail.com
Insights
Cardiovascular risk in kidney transplant patients is high. A functioning arteriovenous fistula and cyclosporine immunosuppression increase aortic pressure augmentation, a key cardiovascular risk factor.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease is the leading cause of death in renal transplant recipients.
- Classical risk factors underestimate cardiovascular risk in this population.
- Arterial wave reflections are emerging as significant predictors of cardiovascular mortality.
Purpose of the Study:
- To assess classical and non-classical risk factors for aortic pressure augmentation.
- To investigate the contribution of these factors in stable renal transplant recipients.
- To identify potential modifiable risk factors for cardiovascular events.
Main Methods:
- Non-invasive pulse wave analysis was used.
- Radial artery waveforms were recorded in 250 stable renal transplant recipients.
- Central aortic waveforms and augmentation index were calculated.
Main Results:
- Female sex, higher heart rate, mean arterial pressure, and age correlated with increased aortic augmentation.
- Persistence of an arteriovenous fistula and longer time on renal replacement therapy were significant correlates.
- Cyclosporine immunosuppression was associated with a higher aortic augmentation index.
Conclusions:
- Arteriovenous fistula presence and cyclosporine treatment are associated with increased aortic augmentation.
- These factors may be reversible contributors to high cardiovascular risk in renal transplant recipients.
- Further research into managing these factors could mitigate cardiovascular mortality.
Background:
Premature cardiovascular disease is the leading cause of death in renal transplant recipients and classical risk factors significantly underestimate the risk. The increased effect of arterial wave reflections on central arteries has recently been shown to be an important independent predictor of cardiovascular mortality in chronic hemodialysis patients. The aim of this study was to assess the contribution of several classical and potential non-classical cardiovascular risk factors on aortic pressure augmentation by the reflected arterial wave in stable renal transplant recipients.
Methods:
Using the non-invasive technique of pulse wave analysis aortic augmentation was investigated in 250 stable renal transplant recipients. Peripheral pulse waveforms were recorded from the radial artery. Central aortic waveforms were then generated and the aortic augmentation index calculated.
Results:
In multivariate analysis, female sex (regression coefficient 7.5 +/- 1.7%; P < 0.001), heart rate (-4.8 +/- 0.5% per 10 beats/min; P < 0.001), mean arterial pressure (4.2 +/- 0.6% per 10 mm Hg; P < 0.001), the persistence of an arteriovenous fistula (4.1 +/- 1.3%; P < 0.005), total time on renal replacement therapy (3.8 +/- 0.9% per 10 years; P < 0.001), height (-3.1 +/- 0.8% per 10 cm; P < 0.001), immunosuppression with cyclosporine (2.8 +/- 1.3%; P < 0.005) and age (2.5 +/- 0.5% per 10 years; P < 0.001) were all important correlates of aortic augmentation index.
Conclusions:
Our findings suggest, to our knowledge for the first time, that both the presence of a functioning arteriovenous fistula and immunosuppressive treatment with cyclosporine are associated with an increased aortic augmentation index in renal transplant recipients and could, therefore, be potential reversible contributors to the high cardiovascular risk profile in these patients.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Kidney Transplant II: Surgical Procedure
Aortic Regurgitation III: Medical Management
Kidney Transplant III: Nursing Management
Continuous Renal Replacement Therapy
